According to McCulloch, Xeris is the only glucagon company “out there advocating for the new guidelines and promoting in the space.” Amphastar's intranasal glucagon dry powder, Baqsimi ...

Intranasal (IN) delivery of medications is ... topical anesthetics, glucagon for hypoglycemia, and agents for epistaxis control. Many new medications, or new uses for common medications via ...

Between 2019 and 2023, prescriptions for nasal spray formulations increased from 4% to 48%, those for glucagon autoinjectors increased by 18%, and those for unmixed syringes dipped from 96% to 31% ...

The Wagoner County Sheriff's Office (WCSO) released body cam video of deputies responding to a diabetic driver who went off ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.